EGFR Combination Therapy Should Become the New Standard First-Line Treatment in Advanced EGFR-Mutant NSCLC. Moore S, Wheatley-Price P. J Thorac Oncol 2021;16:1788-1792.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moore S, Wheatley-Price P. EGFR Combination Therapy Should Become the New Standard First-Line Treatment in Advanced EGFR-Mutant NSCLC. J Thorac Oncol 2021;16:1788-1792.
PMID: 34716002